Skip to content
OpenCapital
Get started

Madison Square Garden Sports MSGS Indefinite-Lived Research and Development Assets

Indefinite-Lived Research and Development Assets at other companies

Live Nation Entertainment logo
Live Nation EntertainmentLYV
——

Other financials

Income statement

See full
Revenue$432.2M+1.9%
Operating income$2.0M-93.9%
Net income-$20.0M-40.5%
EPS (diluted)-$0.83-40.7%

Balance sheet

See full
Cash & equivalents$107.0M+10.9%
Total debt$1.2B-1.9%
Total equity-$295.5M-4.2%
Total assets$1.5B+0.3%

Cash flow

See full
Operating cash flow$57.5M+818%
CapEx$143.0K-93.9%
Free cash flow$57.4M+1,369%

Valuation

See full
Market cap$8.91B+65.5%
Enterprise value$9.97B+52.5%
P/S8.3×+3.2×

Profitability

See full
Operating margin8.4%—
Net margin-2.1%-2.5pp
FCF margin2.8%—

Returns & leverage

See full
Return on equity-6.8%—
Debt / equity0.2×—
Current ratio0.5×-0.1×

Where this comes from

Reported directly by Madison Square Garden Sports in its filing.

Tagged under the XBRL concept us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill.

The official record: Madison Square Garden Sports’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Madison Square Garden Sports's indefinite-lived research and development assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Madison Square Garden Sports's indefinite-lived research and development assets?
Madison Square Garden Sports (MSGS) reported indefinite-lived research and development assets of $103.64M in Q1 2026.
How has Madison Square Garden Sports's indefinite-lived research and development assets changed year-over-year?
Madison Square Garden Sports's indefinite-lived research and development assets decreased by 0.0% year-over-year, from $103.64M to $103.64M.
What is the long-term trend for Madison Square Garden Sports's indefinite-lived research and development assets?
Over 4 years (2021 to 2025), Madison Square Garden Sports's indefinite-lived research and development assets has grown at a -2.0% compound annual growth rate (CAGR), from $112.14M to $103.64M.